EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Abeona Therapeutics Inc., and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / February 6, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Abeona Therapeutics Inc., (“Abeona” or the “Company”) (NASDAQ: ABEO) concerning possible violations of federal securities laws. Investors, who purchased or otherwise acquired PlasmaTech Biopharmaceuticals, Inc. shares between March 31, 2015 and June 19, 2015; and/or Abeona shares between June 22, 2015 and December 9, 2016 inclusive (the “Class Period”), are encouraged to contact the firm in advance of the February 14, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here or call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

Mako Research published a report on SeekingAlpha.com stating, “ABEO science is demonstrably unviable with numerous irrefutable flaws that will lead to failure.” The report found that Steven H. Rouhandeh, the Company’s Executive Chairman and Principal Executive Officer, was the managing director at D. Blech & Co., a brokerage firm that was the subject of SEC investigations during the 1990s, as well as a securities class action suit that ended in a $15 million investor settlement due to allegations that the firm changed the price of some biotech stocks through transactions that falsely inflated the market price of the stocks to maintain the firm’s interest in these stocks. When this information was disclosed to the public, the value of Abeona fell, causing investors harm.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com

SOURCE: Lundin Law PC

ReleaseID: 454359